Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease

Keyphrases

• Anti-inflammatory Effect 100%
• Mouse Model 100%
• Chronic Obstructive Pulmonary Disease 100%
• Trans-anethole 100%
• Blood Pressure 37%
• Lipopolysaccharide 37%
• Porcine Pancreatic Elastase 37%
• Interleukin-6 25%
• Serum Concentration 25%
• Inflammatory Cytokines 25%
• Tumor Necrosis Factor-α 25%
• Lactate Dehydrogenase Activity 25%
• Chronic Lung Inflammation 25%
• Orally Administered 12%
• Airway Obstruction 12%
• Potential Therapeutics 12%
• Macrophages 12%
• Balb C Mice 12%
• Adverse Effects 12%
• Cytokine Production 12%
• Long-term Treatment 12%
• Chronic Inflammation 12%
• Histopathological Changes 12%
• Cell Count 12%
• Mouse Lung 12%
• Intranasal Challenge 12%
• Inflammatory Cell Count 12%
• Lymphocyte Count 12%
• Lung Histology 12%
• Neutrophil Count 12%
• Chronic Inflammatory Lung Disease 12%
• Alveolar Destruction 12%
• Production Pressure 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Antiinflammatory Activity 100%
• Mouse Model 100%
• Chronic Obstructive Lung Disease 100%
• Anethole 100%
• Cytokine 37%
• Lipopolysaccharide 37%
• Pneumonia 37%
• Pig 37%
• Pancreatic Elastase 37%
• Tumor Necrosis Factor 25%
• Interleukin 6 25%
• Lactate Dehydrogenase 25%
• Adverse Event 12%
• Bagg Albino Mouse 12%
• Airway Obstruction 12%
• Chronic Inflammation 12%